Baxter International announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its Artifical Kidney 98 (AK 98) dialysis machine. The next-gen, easy-to-use, portable machine is designed to administer hemodialysis (HD) treatments. Gavin Campbell, GM of Baxter’s U.S. Renal Care business, stated, “We designed this latest version of our AK 98 system to help dialysis providers minimize the operational challenges that can come with administering multiple hemodialysis sessions per machine per day.” The AK 98 takes prescriptions directly from the electronic medical record (EMR) to enable streamlined data management and workflow.

Read more here.